Japanese Consumer Finance Stock News

TSE:4506
TSE:4506Pharmaceuticals

Sumitomo Pharma (TSE:4506) Q4 EPS Loss Tests Bullish Margin Narratives

Sumitomo Pharma (TSE:4506) has wrapped up FY 2026 with fourth quarter revenue of ¥105.5 billion and a basic EPS loss of ¥2.04, capping a year in which trailing twelve month EPS came in at ¥269.0 on revenue of ¥453.3 billion. Over recent periods, the company has seen quarterly revenue move from ¥105.6 billion in Q4 FY 2025 to ¥108.0 billion in Q1 FY 2026, ¥119.1 billion in Q2, and ¥120.6 billion in Q3 before landing at ¥105.5 billion in Q4. EPS shifted from ¥6.08 to ¥28.21, ¥220.63, ¥22.19 and...
TSE:7685
TSE:7685Multiline Retail

Asian Market Insights: Musashi Seimitsu Industry Among 3 Stocks Possibly Below Fair Value

As the Asian markets continue to navigate through a landscape of resilient domestic demand and geopolitical considerations, investors are increasingly on the lookout for opportunities that may be trading below their intrinsic value. Identifying undervalued stocks can offer potential benefits, especially in times when market conditions highlight the importance of strong fundamentals and growth prospects.